Ultragenyx Pharmaceutical shares owned by MPM Oncology Impact Management
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by MPM Oncology Impact Management
from 13F filings
Historical chart of MPM Oncology Impact Management investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by MPM Oncology Impact Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $12M | 396k | 30.08 |
| 2025-06-30 | $14M | 396k | 36.36 |
| 2025-03-31 | $14M | 398k | 36.21 |
| 2024-12-31 | $17M | 391k | 42.07 |
| 2024-09-30 | $18M | 330k | 55.55 |
| 2024-06-30 | $16M | 381k | 41.10 |
| 2024-03-31 | $12M | 246k | 46.69 |
More positions owned by MPM Oncology Impact Management
View all positions for MPM Oncology Impact Management